ACARX
Price
$41.71
Change
-$0.39 (-0.93%)
Updated
Sep 25 closing price
Net Assets
3.24B
GFACX
Price
$74.20
Change
-$0.72 (-0.96%)
Updated
Sep 25 closing price
Net Assets
338.37B
Interact to see
Advertisement

ACARX vs GFACX

Header iconACARX vs GFACX Comparison
Open Charts ACARX vs GFACXBanner chart's image
Alger Capital Appreciation Instl R
Price$41.71
Change-$0.39 (-0.93%)
VolumeN/A
Net Assets3.24B
American Funds Growth Fund of Amer C
Price$74.20
Change-$0.72 (-0.96%)
VolumeN/A
Net Assets338.37B
ACARX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ACARX vs. GFACX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACARX is a Buy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. ACARX (3.24B). ACARX (0.00) and GFACX (0.00) have matching dividends . ACARX was incepted earlier than GFACX: ACARX (23 years) vs GFACX (25 years). ACARX (1.69) is less costly to investors than GFACX (1.36). ACARX is a more actively managed with annual turnover of: 59.80 vs. GFACX (25.00). ACARX has a lower initial minimum investment than GFACX: ACARX (0) vs GFACX (250). ACARX annual gain was more profitable for investors over the last year : 23.42 vs. GFACX (10.71). GFACX return over 5 years is better than : 37.51 vs. ACARX (12.69).
ACARXGFACXACARX / GFACX
Total Expense Ratio1.691.36124%
Annual Report Gross Expense Ratio1.691.36124%
Fund Existence23 years25 years-
Gain YTD30.62416.374187%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.24B338B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year23.4210.71219%
Returns for 3 years98.4965.29151%
Returns for 5 years12.6937.5134%
Returns for 10 years77.7993.0384%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEMCX37.34N/A
N/A
JPMorgan Emerging Markets Equity C
NRECX13.70N/A
N/A
Neuberger Berman Real Estate C
FZAOX35.40N/A
N/A
Fidelity Advisor Small Cap Z
LAMGX18.66N/A
N/A
Lord Abbett Micro Cap Growth A
GEMLX14.26N/A
N/A
Goldman Sachs Emerging Mkts Eq ex. Chn C